Cargando…

Misfolded amyloid-β strains and their potential roles in the clinical and pathological variability of Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Kelley, Sara, Perez-Urrutia, Nelson, Morales, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241421/ https://www.ncbi.nlm.nih.gov/pubmed/35799523 http://dx.doi.org/10.4103/1673-5374.340403

Ejemplares similares

Transmission of amyloid-β pathology in humans: a perspective on clinical evidence
por: Catumbela, Celso S. G., et al.
Publicado: (2023)

Transmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates.
por: Morales, Rodrigo, et al.
Publicado: (2021)

Amyloid pathology arrangements in Alzheimer’s disease brains modulate in vivo seeding capability
por: Duran-Aniotz, Claudia, et al.
Publicado: (2021)

Modeling the Competition between Misfolded Aβ Conformers That Produce Distinct Types of Amyloid Pathology in Alzheimer’s Disease
por: Xu, Guilian, et al.
Publicado: (2022)

Initial failures of anti-tau antibodies in Alzheimer’s disease are reminiscent of the amyloid-β story
por: Imbimbo, Bruno P., et al.
Publicado: (2022)

The tip of the iceberg? The underestimated potential of non-canonical beta-amyloids for Alzheimer’s disease
por: Busch, Lukas, et al.
Publicado: (2023)

Are stress granules the RNA analogs of misfolded protein aggregates?
por: Ripin, Nina, et al.
Publicado: (2022)

Misfolding and Amyloid Aggregation of Apomyoglobin
por: Iannuzzi, Clara, et al.
Publicado: (2013)

Misfolded amyloid-β-42 impairs the endosomal–lysosomal pathway
por: Marshall, Karen E., et al.
Publicado: (2020)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
por: Osborne, Olivia M., et al.
Publicado: (2023)

Therapeutic potential of insulin-like growth factor 2 in Huntington’s disease: controlling proteostasis to alleviate the load of misfolded protein
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2021)

Strain-dependent profile of misfolded prion protein aggregates
por: Morales, Rodrigo, et al.
Publicado: (2016)

Pharmacological strategies for treating misfolded rhodopsin-associated autosomal dominant retinitis pigmentosa
por: Xi, Yibo, et al.
Publicado: (2021)

The biogenesis and biology of amyloid β oligomers in the brain
por: Ashe, Karen Hsiao
Publicado: (2020)

Might Fibroblasts from Patients with Alzheimer’s Disease Reflect the Brain Pathology? A Focus on the Increased Phosphorylation of Amyloid Precursor Protein Tyr(682) Residue
por: Iannuzzi, Filomena, et al.
Publicado: (2021)

Cross-Seeding of Misfolded Proteins: Implications for Etiology and Pathogenesis of Protein Misfolding Diseases
por: Morales, Rodrigo, et al.
Publicado: (2013)

The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau
por: Ashford, J. Wesson
Publicado: (2019)

Alzheimer’s disease amyloid-β pathology in the lens of the eye
por: Moncaster, Juliet A., et al.
Publicado: (2022)

TDP-43 and amyloid precursor protein processing: implications for Alzheimer’s disease
por: Hicks, David A.
Publicado: (2020)

Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
por: Ramanan, Vijay K., et al.
Publicado: (2023)

Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline
por: Stockmann, Julia, et al.
Publicado: (2020)

Amyloid hypothesis through the lens of Aβ supersaturation
por: Guo, Zhefeng
Publicado: (2021)

The incubation period of Alzheimer’s disease and the timing of tau versus amyloid misfolding and spreading within the brain
por: Goudsmit, Jaap
Publicado: (2016)

A crate of Pandora: do amyloids from bacteria promote Alzheimer’s disease?
por: Nguyen, Vu Thu Thuy, et al.
Publicado: (2020)

Phosphorylation of amyloid beta (Aβ) peptides – A trigger for formation of toxic aggregates in Alzheimer's disease
por: Kumar, Sathish, et al.
Publicado: (2011)

Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer’s disease
por: Stocker, Hannah, et al.
Publicado: (2021)

Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline
por: Stockmann, Julia, et al.
Publicado: (2021)

Consequences of redefining Alzheimer's disease in terms of amyloid burden without regard to cognitive decline
por: Robinson, Stephen R., et al.
Publicado: (2018)

Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy
por: Fessel, Jeffrey
Publicado: (2022)

Bayes analysis supports null hypothesis of anti‐amyloid beta therapy in Alzheimer's disease
por: Richard, Edo, et al.
Publicado: (2021)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
por: An, Seong Soo A., et al.
Publicado: (2023)

LISPRO mitigates β-amyloid and associated pathologies in Alzheimer’s mice
por: Habib, Ahsan, et al.
Publicado: (2017)

Early Divergence in Misfolding Pathways of Amyloid‐Beta Peptides
por: Mamone, Salvatore, et al.
Publicado: (2021)

Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
por: Thal, Dietmar R.
Publicado: (2015)

Putative roles of cathepsin B in Alzheimer's disease pathology: the good, the bad, and the ugly in one?
por: Bernstein, Hans-Gert, et al.
Publicado: (2018)

Enhanced neuronal degradation of amyloid-β oligomers allows synapse regeneration
por: Bate, Clive
Publicado: (2015)

The hidden variables problem in Alzheimer's disease clinical trial design
por: Liyanage, S. Imindu, et al.
Publicado: (2018)

Galantamine protects against beta amyloid peptide-induced DNA damage in a model for Alzheimer's disease
por: Castillo, Willian O., et al.
Publicado: (2017)

Recent advancements toward non-invasive imaging of retinal amyloid-beta for early detection of Alzheimer’s disease
por: Wang, Liang, et al.
Publicado: (2022)

Beta‐amyloid pore linked to controlled calcium influx into the cell: A new paradigm for Alzheimer's Disease
por: Pannuzzo, Martina
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_acmgi46pbmrjs5vosfo7cojavh